171 related articles for article (PubMed ID: 26309587)
1. Decreased plasma let-7c and miR-152 as noninvasive biomarker for non-small-cell lung cancer.
Dou H; Wang Y; Su G; Zhao S
Int J Clin Exp Med; 2015; 8(6):9291-8. PubMed ID: 26309587
[TBL] [Abstract][Full Text] [Related]
2. Down-Regulation of circulating miR-23a-3p, miR-101-3p, and miR-let-7c in Women with Idiopathic Recurrent Pregnancy Loss.
Tutunfroush M; Ghorbian S; Mohseni J; Danaii S; Rad MG
Clin Lab; 2022 Oct; 68(10):. PubMed ID: 36250827
[TBL] [Abstract][Full Text] [Related]
3. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
[TBL] [Abstract][Full Text] [Related]
4. Reduced expression levels of let-7c in human breast cancer patients.
Li XX; Gao SY; Wang PY; Zhou X; Li YJ; Yu Y; Yan YF; Zhang HH; Lv CJ; Zhou HH; Xie SY
Oncol Lett; 2015 Mar; 9(3):1207-1212. PubMed ID: 25663883
[TBL] [Abstract][Full Text] [Related]
5. Circulating miR-155, miR-145 and let-7c as diagnostic biomarkers of the coronary artery disease.
Faccini J; Ruidavets JB; Cordelier P; Martins F; Maoret JJ; Bongard V; Ferrières J; Roncalli J; Elbaz M; Vindis C
Sci Rep; 2017 Feb; 7():42916. PubMed ID: 28205634
[TBL] [Abstract][Full Text] [Related]
6. Plasma miR-145, miR-20a, miR-21 and miR-223 as novel biomarkers for screening early-stage non-small cell lung cancer.
Zhang H; Mao F; Shen T; Luo Q; Ding Z; Qian L; Huang J
Oncol Lett; 2017 Feb; 13(2):669-676. PubMed ID: 28356944
[TBL] [Abstract][Full Text] [Related]
7. Cytological effects of honokiol treatment and its potential mechanism of action in non-small cell lung cancer.
Zhang J; Zhang Y; Shen W; Fu R; Ding Z; Zhen Y; Wan Y
Biomed Pharmacother; 2019 Sep; 117():109058. PubMed ID: 31176168
[TBL] [Abstract][Full Text] [Related]
8. Four plasma miRNAs act as biomarkers for diagnosis and prognosis of non-small cell lung cancer.
Jiang HG; Dai CH; Xu YP; Jiang Q; Xia XB; Shu Y; Li J
Oncol Lett; 2021 Nov; 22(5):792. PubMed ID: 34630703
[TBL] [Abstract][Full Text] [Related]
9. Exosomal miR-21/Let-7a ratio distinguishes non-small cell lung cancer from benign pulmonary diseases.
Yang G; Wang T; Qu X; Chen S; Han Z; Chen S; Chen M; Lin J; Yu S; Gao L; Peng K; Kang M
Asia Pac J Clin Oncol; 2020 Aug; 16(4):280-286. PubMed ID: 32525285
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer.
Zhu W; Zhou K; Zha Y; Chen D; He J; Ma H; Liu X; Le H; Zhang Y
PLoS One; 2016; 11(4):e0153046. PubMed ID: 27093275
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and prognostic value of plasma microRNA-195 in patients with non-small cell lung cancer.
Su K; Zhang T; Wang Y; Hao G
World J Surg Oncol; 2016 Aug; 14(1):224. PubMed ID: 27733164
[TBL] [Abstract][Full Text] [Related]
12. Serum miR-10a-5p and miR-196a-5p as non-invasive biomarkers in non-small cell lung cancer.
Bao M; Pan S; Yang W; Chen S; Shan Y; Shi H
Int J Clin Exp Pathol; 2018; 11(2):773-780. PubMed ID: 31938164
[TBL] [Abstract][Full Text] [Related]
13. Investigation of serum miR-411 as a diagnosis and prognosis biomarker for non-small cell lung cancer.
Wang SY; Li Y; Jiang YS; Li RZ
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4092-4097. PubMed ID: 29028091
[TBL] [Abstract][Full Text] [Related]
14. miR-let-7b and miR-let-7c suppress tumourigenesis of human mucosal melanoma and enhance the sensitivity to chemotherapy.
Tang H; Ma M; Dai J; Cui C; Si L; Sheng X; Chi Z; Xu L; Yu S; Xu T; Yan J; Yu H; Yang L; Kong Y; Guo J
J Exp Clin Cancer Res; 2019 May; 38(1):212. PubMed ID: 31118065
[TBL] [Abstract][Full Text] [Related]
15. Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer.
Geng Q; Fan T; Zhang B; Wang W; Xu Y; Hu H
Respir Res; 2014 Nov; 15(1):149. PubMed ID: 25421010
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of miR-204 in plasma is associated with a poor prognosis in patients with non-small cell lung cancer.
Guo W; Zhang Y; Zhang Y; Shi Y; Xi J; Fan H; Xu S
Int J Mol Med; 2015 Dec; 36(6):1720-6. PubMed ID: 26497897
[TBL] [Abstract][Full Text] [Related]
17. The association of let-7c, miR-21, miR-145, miR-182, and miR-221 with clinicopathologic parameters of prostate cancer in patients diagnosed with low-risk disease.
Kurul NO; Ates F; Yilmaz I; Narli G; Yesildal C; Senkul T
Prostate; 2019 Jul; 79(10):1125-1132. PubMed ID: 31045265
[TBL] [Abstract][Full Text] [Related]
18. Clinical value of exhaled breath condensate let-7 in non-small cell lung cancer.
Chen JL; Han HN; Lv XD; Ma H; Wu JN; Chen JR
Int J Clin Exp Pathol; 2020; 13(2):163-171. PubMed ID: 32211096
[TBL] [Abstract][Full Text] [Related]
19. Role of plasma MicroRNAs in the early diagnosis of non-small-cell lung cancers: a case-control study.
Wang X; Zhi X; Zhang Y; An G; Feng G
J Thorac Dis; 2016 Jul; 8(7):1645-52. PubMed ID: 27499953
[TBL] [Abstract][Full Text] [Related]
20. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
